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The role of mitochondria in aging and disease remains contentious more than 40 years after the mitochondrial free
radical theory of aging was first proposed. As part of a wider cross-journal series on contemporary mitochondrial
biology, Longevity & Healthspan presents a thematic series of four reviews that discuss the evidence for and against
the modern incarnations of the theory, and examine the relevance of mitochondrial membrane phospholipid
unsaturation and the interactions of mitochondria with sex hormones.Editorial
Mitochondria are indispensable for aerobic life. Depend-
ing on the tissue and species, they normally occupy
2-20% of the volume of a cell, and it can be up to 50%.
They have their own DNA and undergo constant mo-
tion, fusion and fission. They provide the cell with ATP
formed during the oxidation of carbohydrate, proteins
and fats and are involved in a range of metabolic pathways
including gluconeogenesis, urea synthesis, one-carbon
metabolism, protein synthesis, amino acid metabolism,
haem synthesis and hormone synthesis. They help regu-
late cellular calcium levels, trigger apoptosis, and can
generate reactive oxygen species that are used in cellu-
lar signalling and can cause oxidative damage. Their
many different roles are highlighted in a cross-journal
thematic series including not only articles in Longevity &
Healthspan, but also in Extreme Physiology & Medicine,
Cancer & Metabolism and BMC Biology.
The hallmark of a useful hypothesis is that it stimu-
lates further work and drives progress in its field. The
free radical theory of aging has certainly done that since
Harman proposed it in its general form in 1956 [1] and
in a more mitochondrially-oriented form in 1972 [2].
This theory proposes that the primary cause of aging is
mitochondrial production of free radicals and the mito-
chondrial damage that ensues. The evidence that has
been gathered over the years has led to adjustments and
refinements in the formulation of the hypothesis asCorrespondence: mbrand@buckinstitute.org
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cisely and to square it with experimental observations; as
a result there have been numerous updates and overviews
[3-6]. Many of these have been very influential – I remem-
ber first reading the seminal review by Beckman and
Ames [7] and being impressed by the breadth of the cir-
cumstantial evidence that they highlighted. However,
the perspective has become increasingly critical as the
predicted beneficial effects of many antioxidant treat-
ments and genetic manipulations have failed to materi-
alise [8-14].
Where does that leave us today? On the one hand,
many of the manipulations that should decrease aging
and increase longevity according to the classical versions
of the mitochondrial free radical theory of aging have
failed to do so [15-18], implying that the theory is wrong,
or at best deeply flawed. On the other hand, some of these
manipulations have been very successful [19-22], implying
that that the theory refracts some underlying reality and
still has significant value as a guide to thought and
experiment.
In this thematic series on the role of mitochondria in
longevity and healthspan, Dai et al. [23] discuss the evi-
dence relating to the free radical theory with an emphasis
on results that are generally supportive. They review stud-
ies that support the role of mitochondrial oxidative stress
and dysfunction in aging and healthspan, including car-
diac aging, age-dependent cardiovascular diseases, skel-
etal muscle aging, neurodegenerative diseases, insulin
resistance, diabetes and age-related cancers, then con-
sider potential drugs to improve mitochondrial function
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evidence from long- and short-lived animal species, cal-
orie restriction and genetically modified animals. They
argue that the mitochondrial free radical theory of aging
is in crisis because recent studies have shown no rela-
tionship between free radicals and longevity, and instead
emphasize a role for mitochondrial reactive oxygen spe-
cies as intracellular messengers. They propose that if
mitochondrial reactive oxygen species are involved in
aging and longevity, it is through specific and regulated
cellular processes and not through indiscriminate oxida-
tive damage.
An important mechanism that may link reactive
oxygen species to cellular phenotypes is the oxidation of
polyunsaturated fatty acyl groups in membrane phos-
pholipids [25-27]. This topic is discussed by Valencak
and Azzu [28], who review the many published correla-
tions between mitochondrial membrane phospholipid
composition and longevity. Although there are methodo-
logical issues, the ratio of n-3:n-6 polyunsaturated fatty
acyl groups does appear to correlate with lifespan. How-
ever, they caution against simply relating these two traits
because correlation is consistent with but does not prove
a functional relationship.
One aspect of mitochondria and healthspan that has
received less attention until recently is the role of sex
steroid hormones. This is addressed by Velarde [29],
who discusses the evidence that poorer healthspan is as-
sociated with declining circulating levels of these hor-
mones [30-32]. Mitochondria are involved in steroid
hormone synthesis, and in turn mitochondrial function
may respond to sex hormones. He suggests that a de-
cline in sex steroid hormones and accumulation of mito-
chondrial damage creates a positive feedback loop that
may contribute to progressive degeneration in aging.
Together this set of four reviews illuminates several
aspects of our contemporary understanding of the role
of mitochondria in healthspan and longevity and should
help to light the path ahead. Further unsolicited articles
are encouraged to the series and should be submitted
via the journal’s online submission system.
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